Literature DB >> 12426229

Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease.

Leonardo M Fabbri1, Micaela Romagnoli, Lorenzo Corbetta, Gianluca Casoni, Kamelija Busljetic, Graziella Turato, Guido Ligabue, Adalberto Ciaccia, Marina Saetta, Alberto Papi.   

Abstract

To determine whether patients with fixed airflow obstruction have distinct pathologic and functional characteristics depending on a history of either asthma or chronic obstructive pulmonary disease (COPD), we characterized 46 consecutive outpatients presenting with fixed airflow obstruction by clinical history, pulmonary function tests, exhaled nitric oxide, sputum analysis, bronchoalveolar lavage, bronchial biopsy, and high-resolution computed tomography chest scans. Subjects with a history of COPD (n = 27) and subjects with a history of asthma (n = 19) had a similar degree of fixed airflow obstruction (FEV1: 56 +/- 2 versus 56 +/- 3% predicted) and airway hyperresponsiveness (PC20FEV1: 2.81 [3.1] versus 1.17 [3.3]). Subjects with a history of asthma had significantly more eosinophils in peripheral blood, sputum, bronchoalveolar lavage, and airway mucosa; fewer neutrophils in sputum and bronchoalveolar lavage fluid; a higher CD4+/CD8+ ratio of T cells infiltrating the airway mucosa; and a thicker reticular layer of the epithelial basement membrane. They also had significantly lower residual volume, higher diffusing capacity, higher exhaled nitric oxide, lower high-resolution computed tomography scan emphysema score, and greater reversibility to bronchodilator and steroids. In conclusion, despite similar fixed airflow obstruction, subjects with a history of asthma have distinct characteristics compared with subjects with a history of COPD and should be properly identified and treated.

Entities:  

Mesh:

Year:  2002        PMID: 12426229     DOI: 10.1164/rccm.200203-183OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  106 in total

1.  American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report.

Authors:  Prescott G Woodruff; Maarten van den Berge; Richard C Boucher; Christopher Brightling; Esteban G Burchard; Stephanie A Christenson; MeiLan K Han; Michael J Holtzman; Monica Kraft; David A Lynch; Fernando D Martinez; Helen K Reddel; Don D Sin; George R Washko; Sally E Wenzel; Antonello Punturieri; Michelle M Freemer; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2017-08-01       Impact factor: 21.405

2.  Emphysema in COPD: consequences and causes.

Authors:  G M Turino
Journal:  Thorax       Date:  2006-12       Impact factor: 9.139

3.  The laws of attraction: chemokines, neutrophils and eosinophils in severe exacerbations of asthma.

Authors:  Graziella Turato; Simonetta Baraldo; Renzo Zuin; Marina Saetta
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

4.  Irreversible airway obstruction in asthma.

Authors:  Louis-Philippe Boulet
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

5.  Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction.

Authors:  Eleanor M Dunican; Brett M Elicker; David S Gierada; Scott K Nagle; Mark L Schiebler; John D Newell; Wilfred W Raymond; Marrah E Lachowicz-Scroggins; Selena Di Maio; Eric A Hoffman; Mario Castro; Sean B Fain; Nizar N Jarjour; Elliot Israel; Bruce D Levy; Serpil C Erzurum; Sally E Wenzel; Deborah A Meyers; Eugene R Bleecker; Brenda R Phillips; David T Mauger; Erin D Gordon; Prescott G Woodruff; Michael C Peters; John V Fahy
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

6.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Authors:  Raed A Dweik; Peter B Boggs; Serpil C Erzurum; Charles G Irvin; Margaret W Leigh; Jon O Lundberg; Anna-Carin Olin; Alan L Plummer; D Robin Taylor
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

7.  Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation.

Authors:  M Corradi; P Pignatti; P Manini; R Andreoli; M Goldoni; M Poppa; G Moscato; B Balbi; A Mutti
Journal:  Eur Respir J       Date:  2004-12       Impact factor: 16.671

Review 8.  Differential assessment and management of asthma vs chronic obstructive pulmonary disease.

Authors:  Barbara P Yawn
Journal:  Medscape J Med       Date:  2009-01-21

9.  CD44 variant isoforms are specifically expressed on peripheral blood lymphocytes from asthmatic patients.

Authors:  Chun Yang; Hongyan Liang; Hongli Zhao; Xiaofeng Jiang
Journal:  Exp Ther Med       Date:  2012-04-11       Impact factor: 2.447

10.  Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma.

Authors:  Daphne C Richter; James R Joubert; Haylene Nell; Mace M Schuurmans; Elvis M Irusen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.